Showing results (11-20 of 168) with videos related to
Sort By:
Pageof 17
Mbio|November 19, 2015
A Single Human Cerebral Malaria Histopathologic Study Can Be Worth a Thousand ExperimentsDavid J SullivanInternational Journal for Parasitology|November 19, 2002
Theories on malarial pigment formation and quinoline actionDavid J SullivanCurrent Pharmaceutical Design|September 15, 2012
Plasmodium drug targets outside the genetic control of the parasiteDavid J SullivanJournal of Medicinal Chemistry|September 15, 2006
Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivoJun Lu, Curtis R Chong, Xiaoyi Hu, et al.The Journal of Clinical Investigation|April 28, 2020
Human Plasmodium vivax mosquito experimental transmissionDavid J Sullivan, Peter AgreInfection and Immunity|October 20, 2020
Lactic Acid Supplementation Increases Quantity and Quality of Gametocytes in Plasmodium falciparum CultureRachel West, David J SullivanThe Journal of General Virology|November 26, 2010
Human immunodeficiency virus type 1 long-term non-progressors: the viral, genetic and immunological basis for disease non-progressionKate Poropatich, David J SullivanAntimicrobial Agents and Chemotherapy|January 19, 2017
Impact of Extended Duration of Artesunate Treatment on Parasitological Outcome in a Cytocidal Murine Malaria ModelLeah A Walker, David J SullivanExpert Review of Anti-Infective Therapy|February 26, 2025
Development of antiviral drugs for COVID-19 in 2025: unmet needs and future challengesDaniele Focosi, David J Sullivan, Massimo FranchiniMalaria Journal|September 22, 2011
Discovery of potent, novel, non-toxic anti-malarial compounds via quantum modelling, virtual screening and in vitro experimental validationDavid J Sullivan, Nikola Kaludov, Martin N MartinovPageof 17